Daiken Medical Co., Ltd. provided non-consolidated earnings guidance for the Six months ending September 30, 2022 and Full year 2022. For the Six months, the company expects net sales of JPY 4,170 million, operating profit of JPY 520 million, profit of JPY 360 million and earnings per share of JPY 12.53.

For the year, the company expects net sales of JPY 8,750 million, operating profit of JPY 1,200 million, profit of JPY 840 million and earnings per share of JPY 29.24.